Year: 2015
Type: editorial
Abstract: In the current issue of Cancer, Pasqualini and colleagues report on a study in which they target prostatic tumor vasculature signatures with an apoptosis‐inducing, peptidomimetic drug. The authors of this editorial place this vascular‐targeting discovery into a broader clinical context while focusing on opportunities and challenges in implementing it further.
Source: Cancer
DOI: 10.1002/cncr.29346
Authors: Zachery R. Reichert, Maha HA. Hussain
Institutions: University of Michigan, U-M Rogel Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W1592623565